Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

SNGX

SNGX News

Newswire

08:43

Soligenix announces placement in BioMedWire editorial on rare diseases and breakthrough therapies.

08:37

Soligenix Advances Rare Disease Therapies Amid Growing Healthcare Challenge.

08:37

Soligenix Inc. (NASDAQ: SNGX) Announces Innovative Treatment for Rare CTCL Disease

08:34

Soligenix Announces Placement in BioMedWire Editorial on Rare Diseases.

07:35

Soligenix completes FLASH2 study with 50 patients, exceeds trial estimate.

View More

About SNGX

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More